LEADERSHIP

Francois Nader, M.D.

About Francois

Francois Nader, M.D., has been a director of Alexion since November 2017. Dr. Nader served as President, Chief Executive Officer, and Executive Director of NPS Pharma, a global biotechnology company that was focused on delivering innovative therapies to patients with rare diseases, from 2008 to 2015. Prior to NPS, Dr. Nader was a venture partner at Care Capital, a venture capital firm. He previously served on the North America Leadership Team of Aventis Pharma and its predecessor companies, holding a number of executive positions in integrated healthcare markets and medical and regulatory affairs. He also led global commercial operations at the Pasteur Vaccines division of Rhone-Poulenc. Dr. Nader currently serves as non-executive chairman of Acceleron Pharma, Inc., Prevail Therapeutics and Talaris Therapeutics.

Dr. Nader earned his French Doctorate in Medicine from St. Joseph University in Lebanon and a physician executive MBA from the University of Tennessee.

Dr. Nader is a member of the Audit and Finance Committee and the Science and Innovation Committee.

Tanner, diagnosed with HPP at 4 days old, with a stuffed animal
My hope for Tanner in the future is that he enters into adulthood. I kind of hope that he will be a doctor, and maybe help kids like doctors have helped him.”
RENÉ, TANNER’S MOM LIVING WITH HPP